ELIA, GIUSY
 Distribuzione geografica
Continente #
NA - Nord America 3.123
EU - Europa 1.540
AS - Asia 644
AF - Africa 99
OC - Oceania 6
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.418
Nazione #
US - Stati Uniti d'America 3.081
IT - Italia 816
SE - Svezia 384
CN - Cina 225
SG - Singapore 208
BG - Bulgaria 126
VN - Vietnam 92
DE - Germania 70
CI - Costa d'Avorio 50
CA - Canada 40
GB - Regno Unito 33
TR - Turchia 32
IN - India 28
SN - Senegal 25
IQ - Iraq 23
HK - Hong Kong 21
NG - Nigeria 21
RU - Federazione Russa 18
FI - Finlandia 14
PL - Polonia 11
UA - Ucraina 11
AT - Austria 10
FR - Francia 10
IE - Irlanda 8
NL - Olanda 8
AU - Australia 6
CH - Svizzera 5
GR - Grecia 5
ES - Italia 4
CZ - Repubblica Ceca 3
IR - Iran 3
JP - Giappone 3
TW - Taiwan 3
BR - Brasile 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
IL - Israele 1
KE - Kenya 1
LK - Sri Lanka 1
LT - Lituania 1
PH - Filippine 1
RO - Romania 1
SC - Seychelles 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 5.418
Città #
Fairfield 441
Santa Clara 305
Woodbridge 249
Chandler 229
Ashburn 211
Milan 197
Pisa 180
Houston 177
Seattle 173
Cambridge 155
Wilmington 144
Serra 140
Sofia 126
Ann Arbor 124
Singapore 109
New York 91
Boardman 80
Princeton 80
Lawrence 54
Abidjan 50
Medford 48
Beijing 46
Florence 41
Ottawa 31
Rome 29
Dong Ket 28
Boulder 26
Dakar 25
Istanbul 25
Frankfurt am Main 23
Redwood City 23
San Diego 23
Des Moines 22
Fuzhou 21
Hong Kong 21
Bremen 20
Nanjing 20
Lagos 19
Sulaymaniyah 18
Dearborn 17
Hyderabad 16
Ogden 16
Livorno 15
Carrara 14
Los Angeles 13
Norwalk 13
London 11
Quanzhou 11
Washington 11
Shanghai 10
Vienna 10
Guangzhou 9
Tianjin 9
Warsaw 9
Dublin 8
Amsterdam 7
Wuhan 7
Chengdu 6
Hebei 6
Jacksonville 6
Xiamen 6
Bern 5
Changsha 5
Dallas 5
Nanchang 5
Fremont 4
Helsinki 4
Kilburn 4
Kunming 4
Naples 4
San Francisco 4
Santa Croce sull'Arno 4
Serpukhov 4
Shenyang 4
St Petersburg 4
Toronto 4
Agliana 3
Izmir 3
Jiaxing 3
Lucca 3
Minneapolis 3
Phoenix 3
Pomezia 3
Shenzhen 3
Zhengzhou 3
Absecon 2
Alexandria 2
Basra 2
Bedford 2
Boston 2
Capaccio 2
Cascina 2
Castano Primo 2
Cavriglia 2
Esslingen am Neckar 2
Gabbro 2
Grosseto 2
Hefei 2
Islington 2
Kent 2
Totale 4.175
Nome #
Mechanostructure and composition of highly reproducible decellularized liver matrices 150
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 148
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 141
Characterisation of liver matrices 133
Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy 130
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 129
Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study 121
The association of other autoimmune diseases in patients with Graves’ disease (with or without ophthalmopathy): Review of the literature and report of a large series 121
Liver derived decellularised matrices in bioreactors 112
Liver decellularised matrices in Quasi-Vivo® bioreactors as in-vitro models of hepatic metabolism 111
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells 111
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide 111
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients 109
Novel treatment options for anaplastic thyroid cancer 107
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells 107
The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases 107
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 103
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration 102
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide 102
Novel therapies for thyroid autoimmune diseases: An update 102
Molecular testing in the diagnosis of differentiated thyroid carcinomas 101
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors 99
Novel Therapies for Thyroid Autoimmune Diseases 96
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy 95
Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy 94
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 93
Recent advances in precision medicine for the treatment of anaplastic thyroid cancer 91
New insight in endocrine-related adverse events associated to immune checkpoint blockade 91
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 90
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses 90
Myo-inositol in autoimmune thyroiditis, and hypothyroidism 89
Autoimmune endocrine dysfunctions associated with cancer immunotherapies 89
Chemokines in hyperthyroidism 86
The protective effect of myo-inositol on human thyrocytes 85
Novel treatments for anaplastic thyroid carcinoma 84
Immune and inflammatory cells in thyroid cancer microenvironment 82
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 82
Th1 chemokines in autoimmune endocrine disorders 81
Nutraceuticals in thyroidology: A review of in vitro, and in vivo animal studies 79
Metastases free thyroid cancer patients harbouring TERT mutations may benefit from a more intensive treatment and follow-up 77
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 76
The paramount role of cytokines and chemokines in papillary thyroid cancer: a review and experimental results 74
Molecular targets of tyrosine kinase inhibitors in thyroid cancer 74
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism 71
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies 70
The COVID-19, epidemiology, clinic and prevention 69
Evaluating vandetanib in the treatment of medullary thyroid cancer: Patient-reported outcomes 68
Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases 65
Thyroid autoimmune disorders and cancer 63
The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine 59
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups 58
Endocrine disruptors and thyroid autoimmunity 57
Precision Medicine in Graves’ Disease and Ophthalmopathy 55
L-T4 Therapy in Enteric Malabsorptive Disorders 54
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 52
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 45
Chemokines in thyroid autoimmunity 42
Teprotumumab for the treatment of thyroid eye disease 42
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer 41
Molecular features of aggressive thyroid cancer 38
Graves' disease induced by IFN-β1a therapy: A case report, review of literature and new insights into the pathogenesis 38
Myoinositol in Autoimmune Thyroiditis 33
Thyroid Metastasis from Primary Breast Cancer 32
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series 32
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 32
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture 32
High risk of brain tumors in military personnel: a case control study 31
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 29
Thyroid Autoimmunity and SARS-CoV-2 Infection 26
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 25
Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review 23
Graves' Disease Following SARS-CoV-2 Vaccination: A Systematic Review 21
Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose 17
Hypothyroidism and metabolic cardiovascular disease 14
Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN-ALK Fusion In Vitro 13
Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer 10
Liquid L-T4 therapy in hypothyroid patients with gastric diseases, an observational study 10
Autoimmune Thyroid Diseases and Epigenetics 6
Totale 5.728
Categoria #
all - tutte 19.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020739 0 0 0 0 0 103 116 122 206 79 76 37
2020/2021545 39 58 70 15 23 25 19 60 34 68 25 109
2021/2022798 17 16 31 48 122 102 32 36 70 66 62 196
2022/2023901 134 128 73 53 74 103 38 53 153 6 66 20
2023/2024967 81 93 136 109 138 155 65 23 14 21 39 93
2024/2025832 142 86 81 169 273 81 0 0 0 0 0 0
Totale 5.728